4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-012652
CHIEF OPERATING OFFICER sold 4,875 shares at $22.72 ($110,769)
- CHIEF OPERATING OFFICER acquired 4,875 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · CHIEF OPERATING OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,875 | $2.48 | $12,090 | 4,875 | D |
| 2024-05-06 | Sale : show line 2 in the form 10b5-1 | −4,875 | $22.72 | $110,769 | 0 | D |
| Open-market sales · 4,875 sh · avg $22.72 · $110,769 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-06 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) | −4,875 | 55,842 | D |
Loading xslF345X05/form4-05092024_120559.xml…